Stefan J. Marciniak

University of Cambridge — United Kingdom

Biochemistry, Genetics and Molecular Biology · Life Sciences

49h-index18.2kcitations288works3.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Endoplasmic Reticulum Stress and Disease(66), Medical Imaging and Pathology Studies(47), Occupational and environmental lung diseases(42), Pleural and Pulmonary Diseases(27), Autophagy in Disease and Therapy(23)

Publications273 total

Familial pneumothorax in twins with Tatton-Brown-Rahman DNMT3A overgrowth syndrome
European Journal of Human Genetics·2026Open Access
GCN2 in Proteostasis: Structural Logic, Signalling Networks, and Disease
Apollo (University of Cambridge)·2026Open Access
Understanding risk of poor outcomes in adults hospitalised with respiratory syncytial virus infection: evidence from a multicentre UK cohort
Thorax·2026· 1 citedOpen Access
Familial pneumothorax in twins with Tatton-Brown-Rahman DNMT3A overgrowth syndrome
Apollo (University of Cambridge)·2026Open Access
Volumetric Single‐Molecule Tracking Inside Subcellular Structures
Small·2026Open Access
Supplementary Table S3 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification
2025Open Access
Supplementary Figures S1 to S16 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification
2025Open Access
Supplementary Table S4 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification
2025Open Access
Supplementary Table S5 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification
2025Open Access
Supplementary Table S2 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification
2025Open Access
Supplementary Methods and References from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification
2025Open Access
Supplementary Table S1 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification
2025Open Access
P178 Clinical and biochemical features of adults hospitalised with human metapneumovirus (hMPV): comparison with influenza A and RSV, insights from the UNIVERSAL study
2025
A National Evaluation of Intercostal Chest Drain Removal Strategies
CHEST Journal·2025Open Access
S151 When to test for birt-hogg-dubé syndrome? UK national data
2025
P83 Respiratory complications including pneumothorax in patients receiving tyrosine kinase inhibitors
2025
S142 Proteomic signatures for GCN2 and BMPR2-mutation driven pulmonary vascular disease
2025
WEE1 inhibitors synergise with mRNA translation defects via activation of the kinase GCN2
Nature Communications·2025Open Access
The effect of exenatide (GLP-1a) and sitagliptin (DPP-4i) on paraoxonase 1 (PON1) activity and expression in normal and fructose-fed rats
European Journal of Pharmacology·2025
LUNG FUNCTION AND RADIOGRAPHIC EVOLUTION OF PULMONARY CYSTS OVER TIME IN BIRT-HOGG-DUBE SYNDROME: A RETROSPECTIVE COHORT STUDY
CHEST Journal·2025
page 1 of 14Next →

Frequent Co-authors

David A. Lomas(14), David Ron(11), Elena Miranda(11), A. Ordóñez(9), Joseph E. Chambers(9), Damian C. Crowther(7), Lucy E. Dalton(7), Juan L. Barja(6), Heather P. Harding(5), S. Tamir Rashid(5), Hanna J. Clarke(4), Benoit D. Roussel(4), Sally E. Thomas(4), Ugo Ekeowa(4), Lu Tan(4), Imran Ul Haq(4), Elke Malzer(4), James A. Irving(4), Nicholas R. F. Hannan(3), Ludovic Vallier(3)